Paradigm-shifting platforms II, Non-IO: Targeting Better, Targeting the Intractable

Tuesday, May 5, 2020 | 10:30 – 11:45 am

Moderator:

  • James T. Lee, PhD, Associate Principal, Oncology Lead, Cello Health BioConsulting, previously Defined Health

Panelists:

  • Robert A Copeland, PhD, President & CSO, Accent Therapeutics, Inc.
  • Vicky Richon, PhD, President & CEO, Ribon Therapeutics
  • Mark Rolfe, PhD, SVP, BMS
  • Tingting Zhang-Kharas, PhD, Oncology External Innovation Advisor, Loxo Oncology at Lilly